Early View
ORIGINAL ARTICLE

Evaluating the Diagnostic Impact of the IAC Yokohama System for Breast Fine Needle Aspiration Biopsy Cytopathology: A Prospective Institutional Study

Chayanika Kala

Corresponding Author

Chayanika Kala

Department of Pathology, GSVM Medical College, Kanpur, India

Correspondence:

Chayanika Kala ([email protected])

Search for more papers by this author
Rajneesh Srivastava

Rajneesh Srivastava

Department of Pathology, GSVM Medical College, Kanpur, India

Search for more papers by this author
Sanjay Kala

Sanjay Kala

GSVM Medical College, Kanpur, India

Search for more papers by this author
Lubna Khan

Lubna Khan

Department of Pathology, GSVM Medical College, Kanpur, India

Search for more papers by this author
Neetu Purwar

Neetu Purwar

Department of Pathology, GSVM Medical College, Kanpur, India

Search for more papers by this author
First published: 26 April 2025

Funding: The authors received no specific funding for this work.

ABSTRACT

Introduction

Fine Needle Aspiration Biopsy (FNAB) of the breast is a widely used diagnostic tool for detecting breast lesions, offering high sensitivity and positive predictive value. The International Academy of Cytology (IAC) established the Yokohama System in 2016 to standardise reporting of breast FNAB.

Objective

To categorise FNAB samples according to the IAC Yokohama System, assess the ROM for each category and evaluate the sensitivity, specificity and predictive values for malignancy diagnosis.

Methods

This prospective observational study involved predominantly younger adults with the majority presenting with a palpable breast mass. FNAB samples were collected, stained and examined microscopically. Categories were assigned according to the Yokohama System, and the results were compared with histopathological examination (HPE). Diagnostic metrics and ROM were calculated using statistical analysis.

Results

The study included 428 patients, with malignant cases comprising 49.5% of the samples, benign cases 43.5%, atypical cases 4.2%, suspicious for malignancy cases 1.9% and insufficient material 0.9%. The risk of malignancy (ROM) was 100% for malignant, 87.5% for suspicious for malignancy, 22.2% for atypical, 2.15% for benign and 25% for the insufficient category. Sensitivity, specificity and accuracy varied across groups, with group A, group B and group C showing accuracy at 92.99%, 97.66% and 95.3%, respectively.

Conclusion

The IAC Yokohama System effectively categorises breast FNAB samples, provides accurate diagnostic metrics for malignancy and aids clinical decision-making, particularly in resource-limited settings.

Graphical Abstract

The IAC Yokohama System effectively categorizes breast FNAB, demonstrating high diagnostic accuracy and aiding clinical decision-making, particularly in resource-limited settings.

Conflicts of Interest

The authors declare no conflicts of interest.

Data Availability Statement

All data generated or analysed during this study are included in this article. Further details are available from the corresponding author upon reasonable request.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.